News/ Top stories/ UK & Europe Pharma looking for progress as Brexit talks restart Richard Staines Brexit, ema, generics, Medicines for Europe, regulation 0 Comment Pharma hoping for mutual recognition arrangement Share X Pharma looking for progress as Brexit talks restart https://pharmaphorum.com/news/pharma-looking-progress-brexit-talks-restart/
Articles/ Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis 3 Questions on biosimilars in Europe: Adrian van den Hoven Andrew McConaghie biosimilars, biosimilars Europe, cancer biosimilars, Medicines for Europe 0 Comment Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018. Share X 3 Questions on biosimilars in Europe: Adrian van den Hoven https://pharmaphorum.com/views-and-analysis/biosimilars-3-questions-adrian-van-den-hoven-medicines-europe/